Skip to main content
. 2017 Feb 2;8(31):50774–50781. doi: 10.18632/oncotarget.15037

Figure 2. Survival curve showing overall survival for metastatic breast cancer patients with major depression receiving fluoxetine or no drug (control).

Figure 2